Cargando…
The Potential of Combining Tubulin-Targeting Anticancer Therapeutics and Immune Therapy
Cancer immune therapy has recently shown tremendous promise to combat many different cancers. The microtubule is a well-defined and very effective cancer therapeutic target. Interestingly, several lines of evidence now suggest that microtubules are intimately connected to the body’s immune responses...
Autores principales: | Fong, Alexis, Durkin, Amanda, Lee, Hoyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387102/ https://www.ncbi.nlm.nih.gov/pubmed/30704031 http://dx.doi.org/10.3390/ijms20030586 |
Ejemplares similares
-
Tubulin-interactive stilbene derivatives as anticancer agents
por: Mikstacka, Renata, et al.
Publicado: (2013) -
Peptide-Based Bioconjugates and Therapeutics for Targeted Anticancer Therapy
por: Yang, Seong-Bin, et al.
Publicado: (2022) -
Novel quinolone chalcones targeting colchicine-binding pocket kill multidrug-resistant cancer cells by inhibiting tubulin activity and MRP1 function
por: Lindamulage, I. Kalhari, et al.
Publicado: (2017) -
Anticancer Activity of Chamaejasmine: Effect on Tubulin Protein
por: Fang, Wenlong, et al.
Publicado: (2011) -
Development of Anticancer Peptides Using Artificial Intelligence and Combinational Therapy for Cancer Therapeutics
por: Hwang, Ji Su, et al.
Publicado: (2022)